AU1214383A

AU1214383A – Pyridine derivatives
– Google Patents

AU1214383A – Pyridine derivatives
– Google Patents
Pyridine derivatives

Info

Publication number
AU1214383A

AU1214383A
AU12143/83A
AU1214383A
AU1214383A
AU 1214383 A
AU1214383 A
AU 1214383A
AU 12143/83 A
AU12143/83 A
AU 12143/83A
AU 1214383 A
AU1214383 A
AU 1214383A
AU 1214383 A
AU1214383 A
AU 1214383A
Authority
AU
Australia
Prior art keywords
radical
oxygen atom
optionally substituted
aryl
optionally interrupted
Prior art date
1982-03-10
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Abandoned

Application number
AU12143/83A
Inventor
Andreas Knorr
Horst Meyer
Egbert Wehinger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Bayer AG

Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
1982-03-10
Filing date
1983-03-08
Publication date
1983-09-15

1983-03-08
Application filed by Bayer AG
filed
Critical
Bayer AG

1983-09-15
Publication of AU1214383A
publication
Critical
patent/AU1214383A/en

Status
Abandoned
legal-status
Critical
Current

Links

Espacenet

Global Dossier

Discuss

Classifications

C—CHEMISTRY; METALLURGY

C07—ORGANIC CHEMISTRY

C07D—HETEROCYCLIC COMPOUNDS

C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom

C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members

C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms

C07D211/86—Oxygen atoms

C—CHEMISTRY; METALLURGY

C07—ORGANIC CHEMISTRY

C07D—HETEROCYCLIC COMPOUNDS

C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom

C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members

C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms

C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

A—HUMAN NECESSITIES

A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE

A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

A61P1/00—Drugs for disorders of the alimentary tract or the digestive system

A—HUMAN NECESSITIES

A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE

A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

A61P11/00—Drugs for disorders of the respiratory system

A—HUMAN NECESSITIES

A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE

A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

A61P13/00—Drugs for disorders of the urinary system

A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers

A—HUMAN NECESSITIES

A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE

A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

A61P15/00—Drugs for genital or sexual disorders; Contraceptives

A—HUMAN NECESSITIES

A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE

A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

A61P25/00—Drugs for disorders of the nervous system

A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer’s disease or other forms of dementia

A—HUMAN NECESSITIES

A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE

A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

A61P9/00—Drugs for disorders of the cardiovascular system

A61P9/06—Antiarrhythmics

A—HUMAN NECESSITIES

A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE

A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

A61P9/00—Drugs for disorders of the cardiovascular system

A61P9/08—Vasodilators for multiple indications

A—HUMAN NECESSITIES

A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE

A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

A61P9/00—Drugs for disorders of the cardiovascular system

A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

A—HUMAN NECESSITIES

A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE

A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

A61P9/00—Drugs for disorders of the cardiovascular system

A61P9/12—Antihypertensives

C—CHEMISTRY; METALLURGY

C07—ORGANIC CHEMISTRY

C07D—HETEROCYCLIC COMPOUNDS

C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings

C07D309/32—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members

Abstract

Compounds of the formula in which R is an optionally substituted aryl or heterocyclic radical, R1 is a hydrocarbon radical which is optionally interrupted by 1 oxygen atom in the chain, and/or which is optionally substituted, R4 is an aliphatic hydrocarbon radical having 7 to 14 carbon atoms, which is optionally interrupted by one oxygen atom and/or which is optionally substituted, R2 and R3 each independently is hydrogen, an alkyl radical, an aryl radical or an aralkyl radical, or, for the case where one of the substituents R2 or R3 has the above-mentioned meaning, the other is hydroxymethyl, acetoxymethyl or amino, and X is N-R5, wherein R5 is hydrogen, an alkyl radical which is optionally interrupted by an oxygen atom, a morpholinoalkyl radical, an aryl radical or an aralkyl radical or X is an oxygen atom, when one of the radicals R2 or R3 denotes an amino group, or pharmaceutically acceptable acid addition salts thereof, exhibit hypotensive activity.

AU12143/83A
1982-03-10
1983-03-08
Pyridine derivatives

Abandoned

AU1214383A
(en)

Applications Claiming Priority (2)

Application Number
Priority Date
Filing Date
Title

DE32086288

1982-03-10

DE19823208628

DE3208628A1
(en)

1982-03-10
1982-03-10

NEW COMPOUNDS, METHOD FOR THEIR PRODUCTION AND THEIR USE AS MEDICINAL PRODUCTS

Publications (1)

Publication Number
Publication Date

AU1214383A
true

AU1214383A
(en)

1983-09-15

Family
ID=6157837
Family Applications (1)

Application Number
Title
Priority Date
Filing Date

AU12143/83A
Abandoned

AU1214383A
(en)

1982-03-10
1983-03-08
Pyridine derivatives

Country Status (17)

Country
Link

US
(1)

US4622332A
(en)

EP
(1)

EP0088276B1
(en)

JP
(1)

JPS58164575A
(en)

KR
(1)

KR840004074A
(en)

AT
(1)

ATE19513T1
(en)

AU
(1)

AU1214383A
(en)

CA
(1)

CA1239401A
(en)

DE
(2)

DE3208628A1
(en)

DK
(1)

DK114783A
(en)

ES
(1)

ES8401466A1
(en)

FI
(1)

FI830776L
(en)

GR
(1)

GR78508B
(en)

IL
(1)

IL68075A0
(en)

NO
(1)

NO830612L
(en)

PH
(1)

PH20468A
(en)

PT
(1)

PT76316B
(en)

ZA
(1)

ZA831633B
(en)

Cited By (4)

* Cited by examiner, † Cited by third party

Publication number
Priority date
Publication date
Assignee
Title

AU571316B2
(en)

*

1984-03-27
1988-04-14
Laboratorios Delagrange
3-phenyl-1,4-dihydropyridine derivatives

AU588656B2
(en)

*

1985-12-13
1989-09-21
Bayer Aktiengesellschaft
New fluorine-containing 1,4-dihydropyridines, process for their preparation and their use as medicaments

AU610753B2
(en)

*

1986-04-02
1991-05-23
Fournier Industrie Et Sante
Asymmetrical ester derivatives of 1,4-dihydropyridine-3, 5-dicarboxylic acid

AU708956B2
(en)

*

1995-08-14
1999-08-19
Bayer Aktiengesellschaft
Substituted 4H-pyrans

Families Citing this family (38)

* Cited by examiner, † Cited by third party

Publication number
Priority date
Publication date
Assignee
Title

EP0080220B1
(en)

*

1981-11-17
1986-02-19
FISONS plc
Dihydropyridines, methods for their production and their formulation and use as pharmaceuticals

US4414213A
(en)

*

1982-03-22
1983-11-08
Mead Johnson & Company
Dihydropyridyl cyclic imidate esters and their pharmaceutical use

US4656181A
(en)

*

1982-11-24
1987-04-07
Cermol S.A.
Esters of 1,4-dihydropyridines, processes for the preparation of the new esters, and medicaments containing the same

WO1985000169A1
(en)

*

1983-06-21
1985-01-17
Sandoz Ag
1,4-dihydropyridine derivatives, production thereof and pharmaceutical preparations containing them

JPS60120861A
(en)

*

1983-12-02
1985-06-28
Otsuka Pharmaceut Co Ltd
Dihydropyridine derivative

DE4342196A1
(en)

*

1993-12-10
1995-06-14
Bayer Ag

New 4-phenyl-substituted 1,4-dihydropyridines

JPS60156671A
(en)

*

1984-01-25
1985-08-16
Yamanouchi Pharmaceut Co Ltd
Dihydropyridine derivative and its preparation

US4672068A
(en)

*

1984-05-04
1987-06-09
Fujirebio Kabushiki Kaisha
Antihypertensive 1,4-dihydropyridines having a conjugated ester

FR2568773B1
(en)

*

1984-08-10
1989-03-03
Sandoz Lab

NEW NASAL ADMINISTRATIVE PHARMACEUTICAL COMPOSITIONS

AT381306B
(en)

*

1984-08-28
1986-09-25
Bayer Ag

METHOD FOR PRODUCING UNSYMMETRICAL 1,4-DIHYDROPYRIDINE DICARBONIC ACID ESTERS

NO854021L
(en)

*

1984-10-26
1986-04-28
Bayer Ag

1,4-DIHYDROPYRIDINE HYDROXYAMINES AND PROCEDURES FOR PREPARING THEREOF.

HUT39179A
(en)

*

1984-12-10
1986-08-28
Sandoz Ag
Process for production of derivatives of 1,4-dihydro-piridin

US4833150A
(en)

*

1985-03-14
1989-05-23
Nelson Research & Development Co.
1,4-dihydropyridines

US4659717A
(en)

*

1985-08-21
1987-04-21
Eli Lilly And Company
Dihydropyridines useful in the treatment of angina and stroke

US4735956A
(en)

*

1985-09-13
1988-04-05
Merck & Co., Inc.
Certain 1,4-dihydro-2,6-di-lower hydrocarbyl-4-heterocyclic-3,5-pyridine dicarboxylates which are useful as calcium channel blockers

JPS62174050A
(en)

*

1985-10-21
1987-07-30
Nippon Shoji Kk
3-aminocarbonyl-1, 4-dihydropyridine-5-carboxylic acid derivative, production thereof and drug composition

US4771057A
(en)

*

1986-02-03
1988-09-13
University Of Alberta
Reduced pyridyl derivatives with cardiovascular regulating properties

US4849436A
(en)

*

1986-03-11
1989-07-18
Nelson Research & Development Co.
1,4-dihydropyridines

US4814455A
(en)

*

1986-04-16
1989-03-21
Bristol-Myers Company
Dihydro-3,5-dicarboxylates

US4769382A
(en)

*

1986-09-30
1988-09-06
Institut Organischeskogo Sinteza Leningradsky Nauchno-Issledovatelsky Institut
Preparation for preventing and treatment of skin radiation burn lesions

DE3724909A1
(en)

*

1987-07-28
1989-02-09
Bayer Ag

NEW SUBSTITUTED NITRO-DIHYDROPYRIDINE, METHOD FOR THEIR PRODUCTION AND THEIR USE

US5470982A
(en)

*

1988-01-20
1995-11-28
Bayer Aktiengesellschaft
Disubstituted pyridines

JPH01151557A
(en)

*

1988-11-15
1989-06-14
Otsuka Pharmaceut Co Ltd
Hypotensor

JPH02149563A
(en)

*

1988-11-30
1990-06-08
Nisshin Flour Milling Co Ltd
Production of 1,4-dihydropyridine derivative containing 2-haloethoxycarbonyl group

DK0595164T3
(en)

*

1992-10-30
1997-05-26
Bayer Ag

4-Heterocyclophenyl-substituted dihydropyridines

DE4236707A1
(en)

*

1992-10-30
1994-05-05
Bayer Ag

4-heterocyclyl substituted dihydropyridines

US6001857A
(en)

*

1992-10-30
1999-12-14
Bayer Aktiengesellschaft
Heterocyclyl substituted dihydropyridines

DE4342193A1
(en)

*

1993-12-10
1995-06-14
Bayer Ag

Aryl substituted alkoxycarbonyl-1,4-dihydropyridine-5-carboxylic acid esters

ATE234286T1
(en)

1993-12-10
2003-03-15
Bayer Ag

PHENYL-SUBSTITUTED 1,4-DIHYDROPYRIDINES WITH CEREBRAL ACTIVITY

EE03192B1
(en)

*

1993-12-10
1999-06-15
Bayer Aktiengesellschaft

Isopropyl (2-methoxyethyl) -4- (2-chloro-3-cyanophenyl) -1,4-dihydro-2,6-dimethylpyridine-3,5-dicarboxylate, its enantiomers and intermediate, methods for their preparation and use

DE4429786A1
(en)

*

1994-08-23
1996-02-29
Bayer Ag

Use of substituted 6-amino-4H-pyrans

DE19529859A1
(en)

*

1995-08-14
1997-02-20
Bayer Ag

Use of acyl-substituted aminopyrans

US5977369A
(en)

*

1995-12-28
1999-11-02
Napp Technologies, Inc.
Process to prepare dihydropyridine and derivatives thereof

IT1283793B1
(en)

*

1996-08-23
1998-04-30
Lusochimica Spa

DIHYDROPYRIDINE PREPARATION PROCESS

US6537504B1
(en)

1998-04-06
2003-03-25
Li Young
Method and apparatus for concurrent and sequential multi-step reactions for producing a plurality of different chemical compounds

US6538004B2
(en)

2000-03-03
2003-03-25
Abbott Laboratories
Tricyclic dihydropyrazolone and tricyclic dihydroisoxazolone potassium channel openers

DK1259510T3
(en)

*

2000-03-03
2004-10-04
Abbott Lab

Tricyclic dihydropyrazolone and tricyclic dihydroxiozolone, which open potassium channels

CN105669532B
(en)

*

2014-12-03
2018-11-02
广州市恒诺康医药科技有限公司
Nimodipine soluble derivative and its preparation method and application

Family Cites Families (18)

* Cited by examiner, † Cited by third party

Publication number
Priority date
Publication date
Assignee
Title

DE2117571C3
(en)

*

1971-04-10
1979-10-11
Bayer Ag, 5090 Leverkusen

Asymmetrical 1,4-dihydropyridine-33-dicarboxylic acid esters, process for their preparation and their use as pharmaceuticals

DE2117573C3
(en)

*

1971-04-10
1978-07-27
Bayer Ag, 5090 Leverkusen

Process for the preparation of asymmetrical 1,4-dihydropyridine-3,5dicarboxylic acid esters, and their use as medicaments

US3932645A
(en)

*

1971-04-10
1976-01-13
Farbenfabriken Bayer Ag
Pharmaceutical compositions containing unsymmetrical esters of 1,4-dihydropyridine 3,5-dicarboxylic acid

DE2210672C3
(en)

*

1972-03-06
1980-03-20
Bayer Ag, 5090 Leverkusen

N-substituted asymmetrical 1 ^ -dihydropyridine-S ^ -dicarboxylic acid esters, process for their preparation and their use as medicaments

DE2210674C3
(en)

*

1972-03-06
1981-09-24
Bayer Ag, 5090 Leverkusen

2-Amino-6-methyl-1,4-dihydropyridines, process for their preparation and pharmaceuticals containing them

DE2235406C3
(en)

*

1972-07-19
1982-01-07
Bayer Ag, 5090 Leverkusen

2-Amino-4H-pyrans, process for their preparation and their use as pharmaceuticals

DE2650013C3
(en)

*

1976-10-30
1981-04-02
Bayer Ag, 5090 Leverkusen

1,4-Dihydro-2,6-dimethyl-4- (3-nitrophenyl) -3,5-pyridinedicarboxylic acid isopropyl (2-propoxy-ethyl) ester, process for its preparation and medicinal products containing it

DE2659665A1
(en)

*

1976-12-30
1978-07-13
Nattermann A & Cie

NEW 1,4-DIHYDROPYRIDINE DERIVATIVES

FI64938C
(en)

*

1977-06-20
1984-02-10
Sandoz Ag

PROCEDURE FOR THE FRAMEWORK OF THERAPEUTIC THERAPEUTIC BENSOX A- AND OX BENZOTIADIAZOLYL-1,4-DIHYDROPYRID DERIVATIVES

SU740768A1
(en)

*

1977-11-21
1980-06-15
Институт Органического Синтеза Ан Латвийской Сср
Method of preparing 2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylic acid esters

SU725406A1
(en)

*

1978-08-08
1981-07-30
Ордена Трудового Красного Знамениинститут Органического Синтеза Ah Латвий-Ской Ccp
Esters of 2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylic acid possessing antimetastatic activity

JPS5527054A
(en)

*

1978-08-15
1980-02-26
Gen Foods Corp
Adsorption method

US4307103A
(en)

*

1978-09-08
1981-12-22
Fujisawa Pharmaceutical Co., Ltd.
Dihydropyridine derivative, processes for preparation thereof and pharmaceutical composition comprising the same

DE2847236A1
(en)

*

1978-10-31
1980-05-14
Bayer Ag

NEW DIHYDROPYRIDINE WITH SUBSTITUTED ESTER GROUPS, MORE PROCEDURES FOR THEIR PRODUCTION AND THEIR USE AS MEDICINAL PRODUCTS

US4258042A
(en)

*

1980-04-11
1981-03-24
Usv Pharmaceutical Corporation
Antihypertensive pyridines and compositions

DE3018259A1
(en)

*

1980-05-13
1981-11-19
Bayer Ag, 5090 Leverkusen

1,4-DIHYDROPYRIDINE WITH DIFFERENT SUBSTITUENTS IN 2- AND 6-POSITIONS, METHODS FOR THEIR PRODUCTION AND THEIR USE IN MEDICINAL PRODUCTS

DE3022030A1
(en)

*

1980-06-12
1981-12-17
Bayer Ag, 5090 Leverkusen

4-THIAZOLE or 4-IMIDAZOLE-SUBSTITUTED, 1,4-DIHYDROPYRIDINE, METHOD FOR THE PRODUCTION THEREOF AND THE MEDICINAL PRODUCTS CONTAINING THEM

DE3042769A1
(en)

*

1980-11-13
1982-06-09
Bayer Ag, 5090 Leverkusen

C-3 LINKED 1,4-DIHYDROPYRIDINE, THEIR USE IN MEDICINAL PRODUCTS AND METHOD FOR THE PRODUCTION THEREOF

1982

1982-03-10
DE
DE19823208628
patent/DE3208628A1/en
not_active
Withdrawn

1983

1983-02-21
AT
AT83101626T
patent/ATE19513T1/en
not_active
IP Right Cessation

1983-02-21
EP
EP83101626A
patent/EP0088276B1/en
not_active
Expired

1983-02-21
DE
DE8383101626T
patent/DE3363244D1/en
not_active
Expired

1983-02-22
US
US06/468,621
patent/US4622332A/en
not_active
Expired – Fee Related

1983-02-22
NO
NO830612A
patent/NO830612L/en
unknown

1983-03-01
PT
PT76316A
patent/PT76316B/en
unknown

1983-03-07
IL
IL68075A
patent/IL68075A0/en
unknown

1983-03-08
FI
FI830776A
patent/FI830776L/en
not_active
Application Discontinuation

1983-03-08
GR
GR70727A
patent/GR78508B/el
unknown

1983-03-08
CA
CA000423079A
patent/CA1239401A/en
not_active
Expired

1983-03-08
AU
AU12143/83A
patent/AU1214383A/en
not_active
Abandoned

1983-03-09
JP
JP58037579A
patent/JPS58164575A/en
active
Pending

1983-03-09
ES
ES520441A
patent/ES8401466A1/en
not_active
Expired

1983-03-09
ZA
ZA831633A
patent/ZA831633B/en
unknown

1983-03-09
KR
KR1019830000953A
patent/KR840004074A/en
not_active
Application Discontinuation

1983-03-09
PH
PH28620A
patent/PH20468A/en
unknown

1983-03-09
DK
DK114783A
patent/DK114783A/en
not_active
Application Discontinuation

Cited By (4)

* Cited by examiner, † Cited by third party

Publication number
Priority date
Publication date
Assignee
Title

AU571316B2
(en)

*

1984-03-27
1988-04-14
Laboratorios Delagrange
3-phenyl-1,4-dihydropyridine derivatives

AU588656B2
(en)

*

1985-12-13
1989-09-21
Bayer Aktiengesellschaft
New fluorine-containing 1,4-dihydropyridines, process for their preparation and their use as medicaments

AU610753B2
(en)

*

1986-04-02
1991-05-23
Fournier Industrie Et Sante
Asymmetrical ester derivatives of 1,4-dihydropyridine-3, 5-dicarboxylic acid

AU708956B2
(en)

*

1995-08-14
1999-08-19
Bayer Aktiengesellschaft
Substituted 4H-pyrans

Also Published As

Publication number
Publication date

ES520441A0
(en)

1983-12-16

FI830776L
(en)

1983-09-11

NO830612L
(en)

1983-09-12

JPS58164575A
(en)

1983-09-29

KR840004074A
(en)

1984-10-06

US4622332A
(en)

1986-11-11

GR78508B
(en)

1984-09-27

ATE19513T1
(en)

1986-05-15

PH20468A
(en)

1987-01-14

FI830776A0
(en)

1983-03-08

DK114783A
(en)

1983-09-11

PT76316A
(en)

1983-04-01

PT76316B
(en)

1985-11-25

EP0088276B1
(en)

1986-04-30

EP0088276A1
(en)

1983-09-14

ES8401466A1
(en)

1983-12-16

DE3208628A1
(en)

1983-09-22

CA1239401A
(en)

1988-07-19

ZA831633B
(en)

1983-12-28

IL68075A0
(en)

1983-06-15

DK114783D0
(en)

1983-03-09

DE3363244D1
(en)

1986-06-05

Similar Documents

Publication
Publication Date
Title

AU1214383A
(en)

1983-09-15

Pyridine derivatives

ES8603501A1
(en)

1985-12-16

Novel 1,8-Naphthyridine derivatives, and process for preparation thereof.

GB2248616B
(en)

1994-06-15

Piperazine derivatives

ES8604543A1
(en)

1986-02-01

Piperazine derivatives with anticholinergic and/or antihistaminic activity

DE3474148D1
(en)

1988-10-27

Cephalosporin derivatives and process for their preparation

AU572888B2
(en)

1988-05-19

4-(3-alkynyloxy-2-hydroxy-propyl)-piperazin-i-yl-n- phenyl-acetamide derivatives

ES8401761A1
(en)

1984-01-01

1-(3,4,5-Trimethoxycinnamoyl)-4-aminocarbonylethyl-substituted piperazine derivatives and a process for the preparation thereof.

CA2053705A1
(en)

1992-04-20

Piperazine derivatives

IE790872L
(en)

1978-10-27

Piperazine methanimine derivatives

SE8301785L
(en)

1984-06-04

SET TO MAKE 2-THIOPHENIC ACETIC ACID DERIVATIVES AND INTERMEDIATES REQUIRED FOR THEIR PREPARATION

ES8504772A1
(en)

1985-05-01

7-(4-Pyridyl)-1,8-naphthyridine derivatives and their antibacterial compositions

ES8302712A1
(en)

1983-01-16

Imidazobenzodiazepines

MX9706187A
(en)

1997-11-29

Derivatives of 3-pyrrolidylidene-2-one-cephalosporines.

GB2004273A
(en)

1979-03-28

beta -Lactam compounds, preparation and use

Download PDF in English